David Steffin

Associate Chief, Cell Therapy and Bone Marrow Transplant Program, Inpatient Associate Medical Director, Cell Therapy and Bone Marrow Transplant Program · Baylor College of Medicine

Credentials: · · · ·

History

Cell Therapy and Bone Marrow Transplant Program · Baylor College of Medicine
Present
Baylor College of Medicine
Present
Baylor College of Medicine
Present

Pediatric Hematology/Oncology
Baylor College of Medicine
2018–2021
Pediatrics
Maimonides Medical Center
2015–2018
Baylor College of Medicine - Texas Children's Hospital
2012–2015
Brandeis University
2008–2012
Brandeis University

Research

Interleukin-15-armoured GPC3 CAR T cells for patients with solid cancers
Nature · 2025 · First of 32 authors · 225 citations
Long-term outcomes of GD2-directed CAR-T cell therapy in patients with neuroblastoma
Nature Medicine · 2025 · 58 citations
Long-term follow-up for the development of subsequent malignancies in patients treated with genetically modified IECs
Blood · 2022 · First of 24 authors · Corresponding · 45 citations

Helen Heslop
10 papers
Andras Heczey
7 papers
Malcolm Brenner
7 papers
Anil George
6 papers · 6 as a resident
BS
Baheyeldin Salem
4 papers
Bilal Omer
4 papers
Caridad Martinez
4 papers
Saleh Bhar
4 papers
Zachary Prudowsky
4 papers
Alexandra Stevens
3 papers
BF
Brian Friend
3 papers
Carlos Ramos
3 papers

Clinical trials

GPC3 CAR T Cells With IL-15 and IL-21 for Recurrent ATRT and CNS Rhabdoid Tumors (RADIANT)
Principal investigator · Not yet recruiting · Phase 1
Baylor College of Medicine
2026–2044
Immunotherapy For Adults With GPC3-Positive Solid Tumors Using IL-15 and IL-21 Armored GPC3-CAR T Cells
Principal investigator · Recruiting · Phase 1
Baylor College of Medicine
2025–2043
Interleukin-15 and -21 Armored Glypican-3-specific Chimeric Antigen Receptor Expressed in T Cells for Pediatric Solid Tumors
Principal investigator · Recruiting · Phase 1
Baylor College of Medicine
2024–2042
Interleukin-15 Armored Glypican 3-specific Chimeric Antigen Receptor Expressed in T Cells for Pediatric Solid Tumors
Principal investigator · Active not recruiting · Phase 1
Baylor College of Medicine
2021–2040